Literature DB >> 16944322

Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease.

Pilar del Hoyo1, Alberto García-Redondo, Fernando de Bustos, José Antonio Molina, Youssef Sayed, Hortensia Alonso-Navarro, Luis Caballero, Joaquín Arenas, Félix Javier Jiménez-Jiménez.   

Abstract

Oxidative stress and mitochondrial dysfunction should play a role in the neurodegeneration in Huntington's disease (HD). The most consistent finding is decreased activity of the mitochondrial complexes II/III and IV of the respiratory chain in the striatum. We assessed enzymatic activities of respiratory chain enzymes and other enzymes involved in oxidative processes in skin fibroblasts cultures of patients with HD. We studied respiratory chain enzyme activities, activities of total, Cu/Zn- and Mn-superoxide-dismutase, glutathione-peroxidase (GPx) and catalase, and coenzyme Q(10) (CoQ(10)) levels in skin fibroblasts cultures from 13 HD patients and 13 age- and sex-matched healthy controls. When compared with controls, HD patients showed significantly lower specific activities for catalase corrected by protein concentrations (P < 0.01). Oxidized, reduced and total CoQ(10) levels (both corrected by citrate synthase (CS) and protein concentrations), and activities of total, Cu/Zn- and Mn-superoxide-dismutase, and gluthatione-peroxidase, did not differ significantly between HD-patients and control groups. Values for enzyme activities in the HD group did not correlate with age at onset and of the disease and with the CAG triplet repeats. The primary finding of this study was the decreased activity of catalase in HD patients, suggesting a possible contribution of catalase, but not of other enzymes related with oxidative stress, to the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944322     DOI: 10.1007/s11064-006-9110-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  41 in total

1.  Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease.

Authors:  Isaac Túnez; René Drucker-Colín; Ignacio Jimena; Francisco J Medina; Maria del Carmen Muñoz; José Peña; Pedro Montilla
Journal:  J Neurochem       Date:  2006-03-08       Impact factor: 5.372

2.  Age dependence of striatal neuronal death caused by mitochondrial dysfunction.

Authors:  S R Bossi; J R Simpson; O Isacson
Journal:  Neuroreport       Date:  1993-01       Impact factor: 1.837

3.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Assays of glutathione peroxidase.

Authors:  L Flohé; W A Günzler
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease.

Authors:  A Santamaría; F Pérez-Severiano; E Rodríguez-Martínez; P D Maldonado; J Pedraza-Chaverri; C Ríos; J Segovia
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

6.  Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

Authors:  S E Browne; A C Bowling; U MacGarvey; M J Baik; S C Berger; M M Muqit; E D Bird; M F Beal
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

7.  Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.

Authors:  O Hansson; A Petersén; M Leist; P Nicotera; R F Castilho; P Brundin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

8.  Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

Authors:  W J Koroshetz; B G Jenkins; B R Rosen; M F Beal
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

9.  Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice.

Authors:  Gabriele Schilling; Alena V Savonenko; Michael L Coonfield; Johanna L Morton; Esther Vorovich; Alexa Gale; Christopher Neslon; Ning Chan; Michelle Eaton; David Fromholt; Christopher A Ross; David R Borchelt
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

10.  Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease.

Authors:  N Barroso; Y Campos; R Huertas; J Esteban; J A Molina; A Alonso; E Gutierrez-Rivas; J Arenas
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

View more
  24 in total

1.  Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity.

Authors:  Xueyi Li; Clive Standley; Ellen Sapp; Antonio Valencia; Zheng-Hong Qin; Kimberly B Kegel; Jennifer Yoder; Laryssa A Comer-Tierney; Miguel Esteves; Kathryn Chase; Jonathan Alexander; Nicholas Masso; Lindsay Sobin; Karl Bellve; Richard Tuft; Lawrence Lifshitz; Kevin Fogarty; Neil Aronin; Marian DiFiglia
Journal:  Mol Cell Biol       Date:  2009-09-14       Impact factor: 4.272

Review 2.  Mitochondrial functional alterations in relation to pathophysiology of Huntington's disease.

Authors:  Mritunjay Pandey; Kochupurackal P Mohanakumar; Rajamma Usha
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

3.  Coenzyme Q10 deficiency in patients with Parkinson's disease.

Authors:  Laurie K Mischley; Jason Allen; Ryan Bradley
Journal:  J Neurol Sci       Date:  2012-04-27       Impact factor: 3.181

4.  Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.

Authors:  N Klepac; M Relja; R Klepac; S Hećimović; T Babić; V Trkulja
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

5.  Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

Authors:  Antonio Valencia; Ellen Sapp; Jeffrey S Kimm; Hollis McClory; Patrick B Reeves; Jonathan Alexander; Kwadwo A Ansong; Nicholas Masso; Matthew P Frosch; Kimberly B Kegel; Xueyi Li; Marian DiFiglia
Journal:  Hum Mol Genet       Date:  2012-12-07       Impact factor: 6.150

6.  Oxidative stress and glutathione response in tissue cultures from persons with major depression.

Authors:  Sara A Gibson; Željka Korade; Richard C Shelton
Journal:  J Psychiatr Res       Date:  2012-07-28       Impact factor: 4.791

7.  Coenzyme Q10 effects in neurodegenerative disease.

Authors:  Meredith Spindler; M Flint Beal; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

Review 8.  Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

Authors:  Sylvette Ayala-Peña
Journal:  Free Radic Biol Med       Date:  2013-04-18       Impact factor: 7.376

9.  Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease.

Authors:  Yifeng Du; Michael C Wooten; Marie W Wooten
Journal:  Neurobiol Dis       Date:  2009-05-28       Impact factor: 5.996

Review 10.  A mitochondrial basis for Huntington's disease: therapeutic prospects.

Authors:  J Chakraborty; U Rajamma; K P Mohanakumar
Journal:  Mol Cell Biochem       Date:  2013-12-29       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.